HB
NVS icon

Homrich & Berg’s Novartis NVS Stock Holding History

Homrich & Berg’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,412
Closed -$263K – 327
2018
Q3 		$263K Buy
3,412
+123
+4% +$9.09K 0.02% 277
2018
Q2 		$223K Sell
3,289
-465
-12% -$32.1K 0.02% 291
2018
Q1 		$272K Buy
3,754
+203
+6% +$15.5K 0.02% 273
2017
Q4 		$267K Sell
3,551
-2,605
-42% -$197K 0.02% 272
2017
Q3 		$474K Buy
+6,156
New +$465K 0.04% 196

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Homrich & Berg's NVS Position: Q4 2018 in Review

Homrich & Berg sold out of Novartis (NVS) in Q4 2018, closing a stake of 3,412 shares — an estimated $263K sold.

Homrich & Berg first reported a position in NVS in Q3 2017 and held it in 5 quarters. The position peaked at $474K in Q3 2017. 1,087 funds tracked by Wall St. Rank hold NVS as of Q4 2018.

  • Homrich & Berg reported no remaining Novartis position as of Q4 2018 after selling out during the quarter.
  • Homrich & Berg sold 3,412 Novartis shares in Q4 2018, an estimated $263K.
  • Homrich & Berg first reported a position in Novartis in Q3 2017 and held it in 5 quarters.
  • Homrich & Berg's Novartis position peaked at $474K in Q3 2017.
  • 1,087 funds tracked by Wall St. Rank held Novartis as of Q4 2018.

Based on Homrich & Berg's 13F filing for Q4 2018, filed 6 Feb 2019.